U-Blot® Research Grade Anti-Human IL1B/IL1F2 (DLX2323)Cat. No. WA2032$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human IL1B/IL1F2 (DLX2323)Cat. No. WA2032
U-Blot® Research Grade Anti-Human IL1B/IL1F2 (CDP484)Cat. No. WA2031
U-Blot® Research Grade Anti-Human IL1A/IL1F1 (XB2001)Cat. No. WA2030
U-Blot® Research Grade Anti-Human IL18/IL1F4 (GSK 1070806)Cat. No. WA2029
U-Blot® Research Grade Anti-Human IL18/IL1F4 (AVTX-007)Cat. No. WA2028
U-Blot® Research Grade Anti-Human IL18/IL1F4 (ABT-325)Cat. No. WA2027
U-Blot® Research Grade Anti-Human IL17RB (SM17)Cat. No. WA2026
U-Blot® Research Grade Anti-Human IL17A Antibody (XAB4)Cat. No. WA2025
U-Blot® Research Grade Anti-Human IL17A (SCH 900117)Cat. No. WA2024
U-Blot® Research Grade Anti-Human IL17A (QX 002N)Cat. No. WA2023
U-Blot® Research Grade Anti-Human IL17A (CNTO-6785)Cat. No. WA2022
U-Blot® Research Grade Anti-Human IL17A (CJM112)Cat. No. WA2021